BioLife Solutions, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
BioLife Solutions, Inc. (BLFS) reported Adjustments to Additional Paid in Capital, Warrant Issued of $374.39 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-09.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2018-03-09
- BioLife Solutions, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $374.39K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|
| 2016-12-31 | $374.39K 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |